Background {#Sec1}
==========

Socioeconomic inequalities in cancer survival outcomes exist, but the reasons for this are not fully understood \[[@CR1]--[@CR3]\]. Survival differences are likely to reflect later-stage disease at diagnosis \[[@CR2], [@CR4], [@CR5]\] partly as a consequence of delayed cancer symptom presentation in people from lower socioeconomic groups \[[@CR6]\]. By eradicating socioeconomic inequalities at stage of diagnosis, it is estimated that 5600 patients in the UK annually could be diagnosed with earlier stage disease \[[@CR7]\], and that 11 % of deaths from cancer could be avoided if three-year survival in lower socioeconomic groups matched that in higher socioeconomic groups \[[@CR1]\].

'Patient delay' is defined as the time between discovery of a cancer symptom and the initial visit to a healthcare professional. It accounts for the greatest proportion of delay time in the pathway from symptom discovery to the start of cancer treatment \[[@CR8]--[@CR10]\] and has been associated with socioeconomic deprivation \[[@CR6]\]. Patient delay has been conceptualised in Walter et al*.*'s Model of Pathways to Treatment, with various stages involving an 'appraisal interval' during which the individual detects a bodily change, and a 'help seeking interval' in which the individual decides to seek medical help (see Fig. [1](#Fig1){ref-type="fig"} \[[@CR11]\]). Evidence suggests that knowledge of cancer symptoms is important during the appraisal stage, with potential misattribution of symptoms attenuating the decision to present \[[@CR12], [@CR13]\]. Beliefs about cancer are considered to be important in both the appraisal and help-seeking stages, where emotions such as fear might influence interpretation of symptoms \[[@CR12]\] and the decision to seek medical help \[[@CR6], [@CR14]--[@CR17]\]. Barriers such as competing life events and ease of getting a medical appointment are thought to delay symptom presentation during the help-seeking interval \[[@CR11]\].Fig. 1Model of pathways to treatment. Produced with permission of SAGE Publications Ltd., London, Los Angeles, New Delhi, Singapore and Washington DC, from Walter FM, Scott SE, Webster A, Emery JD. 'The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis'. J Health Services Research & Policy (© Walter, 2012)

The contribution of socioeconomic and other demographic factors to delayed presentation has been highlighted in the Model of Pathways to Treatment, and more recently in the updated National Awareness and Early Diagnosis Initiative (NAEDI) framework designed to conceptualise the route from public awareness and beliefs about cancer to cancer survival outcomes (\[[@CR18]\]). Empirical evidence supports associations between lower socioeconomic group and poor cancer symptom knowledge \[[@CR19]\], fearful and fatalistic beliefs about cancer \[[@CR20]\] and emotional barriers such as worry about what the doctor may find \[[@CR19]\]. These findings help to explain why people from lower socioeconomic groups tend to present with more advanced stage cancers, and hence have worse survival outcomes \[[@CR1]--[@CR5]\]. However, a more detailed understanding of psychosocial influences on the relationship between socioeconomic deprivation and cancer symptom presentation is essential to developing behavioural interventions designed to promote timely presentation and reduce socioeconomic inequalities in cancer outcomes.

Attempts to understand why people might delay seeking medical help for cancer symptoms have examined actual or anticipated symptom presentation behaviour, exploring perceived barriers to symptom presentation. Prospective study designs are difficult due to follow-up of a large sample, so studies frequently use retrospectively recalled or hypothetically anticipated symptom study designs. Previous reviews have focused on tumour site-specific delay factors \[[@CR15], [@CR16], [@CR21]\] or common cancers only \[[@CR6]\], or have been restricted to qualitative studies \[[@CR17]\] and patients with cancer \[[@CR6], [@CR16], [@CR17]\]. The purpose of the current systematic review was to explore how knowledge, beliefs and barriers/facilitators to symptom presentation affect actual or anticipated cancer symptom presentation in relation to socioeconomic group and across all tumour sites.

Method {#Sec2}
======

Identification of included studies followed the PRISMA guidelines \[[@CR22]\]. The protocol was registered on PROSPERO (CRD42014013220 \[[@CR23]\]) and is available on the NIHR HTA programme website ([www.hta.ac.uk](http://www.hta.ac.uk)). At all stages of the search, data extraction and quality appraisal, 10 % of studies were double checked for consistency by a second member of the research team (RR). All discrepancies were resolved through discussion.

Search strategy {#Sec3}
---------------

The literature was searched up to July 2015 on the electronic databases of MEDLINE, PsychINFO, EMBASE and CINAHL. The de-duplicate function was used on Ovid and CINAHL before reviewing abstracts. Manual searches of reference lists of included studies were performed. A SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research type) search strategy tool was used for retrieval of studies (see Additional file [1](#MOESM1){ref-type="media"}: Appendix 1 \[[@CR24]\]). Databases were searched using terms relating to *symptom presentation, cancer symptom knowledge, beliefs about cancer, perceived barriers and facilitators to symptom presentation* (see Additional file [1](#MOESM1){ref-type="media"}: Appendix 1)*.*

Inclusion criteria {#Sec4}
------------------

Publications that measured and reported data for symptom presentation and socioeconomic group were included. 'Symptom presentation' was defined as actual symptom presentation (retrospectively recalled) or anticipated symptom presentation (hypothetically estimated) measured as continuous (time to presentation) or binary (did/did not present) variables. 'Socioeconomic group' was defined in terms of individual level socioeconomic indicators including education, income, home/car ownership, occupation and employment, and/or area-level indicators based on postcode. In addition, publications were included if they measured and reported one or more of the following domains of interest:'Knowledge': studies which assessed knowledge for the symptoms of cancer through recall e.g. 'What symptoms of cancer can you list?' or recognition methods e.g. 'Which of these are symptoms of cancer?', or through retrospective recall of symptom interpretation at the time of symptom discovery.'Beliefs': studies which explored any positive (e.g. beliefs about the benefits of early diagnosis and curability) or negative (e.g. fear and fatalism) beliefs surrounding cancer.'Perceived barriers/facilitators': studies which assessed any anticipated or actual barriers or facilitators to symptom presentation.

There were no restrictions on date of publication or study methodology. Only English language studies from high income countries as classified by Organisation for Economic Co-operation and Development (OECD) membership (OECD, 2014 \[[@CR25]\]) were included.

Exclusion criteria {#Sec5}
------------------

Studies that did not measure and report symptom presentation, socioeconomic group and one or more of the domains of interest were excluded. Studies not relating to cancer, and those examining screening behaviour, self-examination behaviour, efficacy of interventions, genetic risk, healthcare professionals' perspective, cancer prevention, treatments for cancer or living with cancer and studies involving children were excluded. Studies from low/middle income countries, not written in English, review papers or conference abstracts were excluded (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2PRISMA flow diagram. Produced using a downloadable template available at <http://www.prisma-statement.org/> (Moher et al, 2009 \[[@CR22]\])

Data extraction and synthesis {#Sec6}
-----------------------------

Data were extracted onto a template using the following headings: method, sample characteristics, tumour site, symptom presentation, knowledge, beliefs, perceived barriers/facilitators and socioeconomic group measure. A meta-analysis was precluded due to the heterogeneity of included studies and a narrative synthesis was performed \[[@CR26]\].

Critical appraisal {#Sec7}
------------------

The methodological quality of all included studies was examined using the Critical Appraisal Skills Programme tool (CASP, 2014 \[[@CR27]\]) appropriate for the study design. Quality was assessed according to each domain on the CASP checklists: rationale of study, methodology, design, recruitment, data collection, data analysis, ethical issues, reporting of findings and contribution to research*.* Overall quality was categorised as good, medium or poor.

Results {#Sec8}
=======

The search returned a total of 1536 studies after 810 duplicates had been removed. A total of 1309 studies was excluded based on title and abstract, leaving 227 studies to be read in full. A total of 60 studies met the inclusion criteria (see Fig. [2](#Fig2){ref-type="fig"}). Eleven of these studies were found through hand searching reference lists.

Included studies employed qualitative methods (*n* = 15), quantitative methods (*n* = 42) and mixed methods (*n* = 3). Quality of studies was good (*n* = 18), medium (*n* = 37) and poor (*n* = 5). Limitations of lower quality studies included measuring but not reporting socioeconomic group differences for all outcome measures, leaving a long period of time between cancer diagnosis and participation in the study and recruitment of samples biased towards higher socioeconomic groups. The overall combined percentage agreement between raters (GM and RR) for inclusion/exclusion of studies, critical appraisal and data extraction was 87 %.

A total of 53 studies examined time to symptom presentation, seven studies reported presentation behaviour (if participants did or did not present or anticipate presenting to their doctor with reported symptoms), 45 studies measured actual symptom presentation, 15 studied anticipated symptom presentation, 46 studies assessed knowledge for cancer symptoms, 32 studies explored beliefs about cancer and 50 studies examined perceived barriers/facilitators to symptom presentation. The numbers of studies by tumour site were as follows: breast (*n* = 22), any cancer/multiple tumour sites (*n* = 15), colorectal (*n* = 7), skin (*n* = 6), oral and pharyngeal (*n* = 3), ovarian (*n* = 3), lung (*n* = 2), gynaecological (*n* = 1), and prostate (*n* = 1) (see Table [1](#Tab1){ref-type="table"}). Results are presented according to domain headings.Table 1Table of included studiesStudyMethodSampleCountryTumour siteSocio-economic measureMeasures: Knowledge (K), Beliefs (B), Perceived barriers (PB), Perceived facilitators (PF), Symptomatic Presentation (SP)Measure of association between variables of interest and socioeconomic indicator (qualitative studies not applicable)Quality appraisalBrain et al. (2014) \[[@CR28]\]Hypothetical Quantitative1043 women. Aged 50 years and overWalesOvarianPostcode, educationK: Recognition (mean, 6.85 symptoms)\
B: Cancer worry\
PB: Emotional and practical barriers\
SP: Sought medical help in under 3 weeks (*n* = 898)K: Lower education associated with lower knowledge (F(~2,\ 1005~) = 8.23, *p* \< 0.001); higher deprivation (postcode) associated with lower knowledge (F~3,886~ = 2.82, *p* \< 0.05)\
B: NR\
PB: NR\
SP: Higher education associated with longer time to SP, (OR = 2.64, p ≤ 0.001); NS difference between deprivation by postcode and anticipated delay (X^2^~(3)~ = 6.73, *p* \> 0.05) NSGoodBrouha et al. (2005) \[[@CR76]\]Retrospective Quantitative189 men and women. Mean age: 59 yearsHollandOral and PharyngealEducation, incomeK: Symptom interpretation ('cancer', *n* = 2), misattribution of symptoms to dental problems delayed SP\
PB: Symptom did not interfere with daily life\
PF: Persistence of symptom, development of new symptom\
SP: Mean time to symptom presentation (pharyngeal, 45 days; oral, 28 days)K: NR\
PB: NR\
PF: NR\
SP: Education and income not associated with time to SP (statistics NR)MediumBurgess et al. (1998) \[[@CR45]\]Retrospective Qualitative185 women. Mean age: 54 yearsUKBreastOccupationK: Symptom interpretation (46 % thought their symptom indicated cancer)\
B: Fear\
PF: Symptom disclosure, appearance of new symptoms, appointment booked with GP for another reason\
SP: Waited over 3 months to seek medical help (19 %)MediumBurgess et al. (2000) \[[@CR67]\]Retrospective Qualitative158 women. Mean age: 53 yearsUKBreastOccupationPB: Life events\
SP: Waited over 3 months to seek medical help (18 %)MediumBurgess et al. (2001) \[[@CR43]\]Retrospective Qualitative46 women. Mean age: 54.1 yearsUKBreastOccupationK: Symptom interpretation ('lump' most attributed to cancer)\
B: Consequences of treatment\
PB: Not wanting to bother the doctor, poor health service utilisation, competing life priorities\
PF: Symptom disclosure, change in symptom\
SP: Waited over 3 months to seek medical help (*n* = 31)MediumCameron and Hinton (1968) \[[@CR58]\]Retrospective Quantitative83 womenUKBreastEducation, husband's occupationK: Symptom interpretation\
B: Fear, worry\
SP: 61 % sought medical help within 1 monthK: NR\
B: NR\
SP: Higher education associated with shortest time to SP for lump symptoms (*x*^2^ = 6.6, *p* \< 0.05); Higher social group (husband's occupation) associated with shortest time to SP (*x*^2^ = 3.02, *p* \< 0.01)PoorCaplan (1995) \[[@CR44]\]Retrospective Quantitative162 womenUSBreastIncome, education, employmentPB: Fluctuating symptoms, relationship with GP\
SP: Waited over 2 months to seek medical help (*n* = 27)PB: NR\
SP: Lower socioeconomic group (various indices) associated with longer time to SP, but NS: High vs low income (OR 2.56, 95 % CI: 0.68-8.64\*); High vs low education (OR 1.07, 95 % CI: 0.41-2.77\*); Working vs non-working (OR 0.72, 95 % CI: 0.27-1.99\*)PoorCarter-Harris et al. (2015) \[[@CR69]\]Retrospective Qualitative11 men (*n* = 4) and women (*n* = 7). Age range: 40-76 yearsUSLungEducation, employmentK: Symptom interpretations (one participant was alarmed at symptoms)\
PB: Vague and intermittent nature of symptoms\
PF: Worsening of symptoms, good relationship with GP\
SP: Immediate (*n* = 1)MediumChonjnacka-Szawlowska et al. (2013) \[[@CR36]\]Retrospective\
Quantitative301 men (*n* = 186) and women (*n* = 115). Mean age: 42.3 yearsPolandAllEducationK: Recall, mean: 1.51\
B: Fatalism and cancer curability\
SP: Mean time to symptom presentation: 6 months and 10 days; stage of cancerK: NR\
B: NR\
SP: NS correlation between education and stage of cancer (statistics NR)MediumCoates et al. (1992) \[[@CR42]\]Retrospective Quantitative735 women (410 black and 325 white). Age range: 20 to 79USBreastEducation, occupation, poverty index (income/no of people in household)K: Symptom interpretation\
B: Fatalism\
PB: Symptom disclosure, other comorbid conditions, appointment with doctor booked for another reason\
SP: Median time to symptom presentation (black women, 16 days; white women, 14 days)K: NR\
B: NR\
PB: NR\
SP: Higher education associated with shorter time to SP (Mantel-cox 1.43, 95 % CI: 1.11-1.86, *p* \< 0.05); Low deprivation (poverty index) associated with shorter time to SP (Mantel-Cox 1.24, 95 % CI: 1-1.54, *p* \< 0.05)GoodCockburn et al. (2003) \[[@CR54]\]Retrospective Quantitative1332 men (40 %) and women (60 %). Aged 40 years and overAustraliaColorectal (Bowel)EducationK: Recall (25 % could not recall any symptoms), symptom interpretation\
B: Benefits of early diagnosis\
SP: 306 had experienced a symptom, 31.9 % did not seek medical helpK: Higher education associated with higher K of symptoms (PR 0.93, 95 % CI: 0.89-0.96\*)\
B: Higher education more likely to hold positive beliefs about the benefits of early diagnosis (statistics NR)\
SP: NRMediumEsteva et al. (2013) \[[@CR70]\]Retrospective Quantitative795 men (*n* = 489) and women (*n* = 291)SpainColorectalSocial class, educationK: Symptom interpretation ('not serious', 65.6 %)\
PF: Symptom disclosure, good relationship with GP (trust)\
SP: Median time to symptom presentation (19 days)K: NR\
SP: NS association between social class and time to SP (statistics NR), NS association between education and time to SP (statistics NR)MediumFacione and Facione (2006) \[[@CR59]\]Retrospective Qualitative28 women. Mean age: 42.34 yearsUSBreastIncome, education, health insuranceK: Symptom interpretation\
B: Fear, fatalism, benefits of early diagnosis\
PB: Worry about losing relationship with partner if diagnosed with cancer\
PF: Symptom disclosure\
SP: Sought medical help after 3 months (*n* = 15)MediumFacione et al. (2002) \[[@CR56]\]Hypothetical Quantitative669 women. Mean age: 46.95 yearsUSBreastIncome, education, health care insuranceK: Recognition (10 % recognised all or all but one symptoms)\
B: Fatalism\
PB: Difficulties with access, prejudice in health care, concerns about deportation, use of alternative therapies\
SP: Likely to delay (23.7 %).K: Higher education associated with higher symptom recognition (F~3,690~ = 32.32, *p* \< 0.001)\
B: NR\
PB: NR\
SP: Lack of insurance associated with longer time to SP (Cramer's V = 0.187, *p* \< 0.001); Lower education associated with longer time to SP (Cramer's V = 0.288, *p* \< 0.001); Lower income associated with longer time to SP (Cramer's V = 0.291, *p* \< 0.001)GoodFacione et al. (1997) \[[@CR84]\]Hypothetical Quantitative352 African American or Black women. Mean age: 38.6 yearsUSBreastIncome, Education, EmploymentB: Fear, fatalism\
PB: Poor health service utilization\
SP: 11.6 % = strong disposition to SP.B: NR\
PB: NR\
SP: Stronger disposition to SP associated with lower education (r = 0.19, *p* \< 0.01) and lower income (r = 0.32, *p* \< 0.001)MediumFacione and Dodd (1995) \[[@CR83]\]Retrospective Qualitative39 women. Mean age: 49.6 yearsUSBreastIncome, educationK: Symptom interpretation\
B: Fear\
PB: Competing life priorities\
PF: Appearance of new symptom, worsening of symptoms, symptom disclosure\
SP: 59 % sought medical help within 1 weekMediumFitzpatrick et al. (1998) \[[@CR57]\]Hypothetical Quantitative280 men. Mean age: 53.7 yearsIrelandProstateHealth insurance, occupationB: Fear\
PB: Poor health service utilisation, dislike of doctors, embarrassment\
SP: 81 % would seek medical help if developed urinary symptomsB: NR\
PB: NR\
SP: Non-manual social class associated with higher willingness to attend GP with symptoms (OR 1.8, *p* \< 0.05\*\*)GoodForbes et al. (2011) \[[@CR29]\]Hypothetical Quantitative1515 women from various ethnic groups (White, South Asian, Black). Aged 30 years and overUKBreastPostcode (IMD)K: Recognition (18 % recognised 5 or more non-lump symptoms)\
PB: self-efficacy, worry what the doctor might find, embarrassment, worry about wasting doctors time, difficulty getting an appointment\
SP: 73 % would seek help within 1 weekK: Differences between ethnic groups for cancer awareness not due to IMD score or lower level of education (statistics NR)\
PB: Differences between ethnic groups for PB not due to IMD score (statistics NR)\
SP: NRGoodForbes et al. (2014) \[[@CR64]\]Retrospective Quantitative1999 men (*n* = 1077) and women (*n* = 922). Aged 50 or overUKAllPostcodeK: Symptom interpretation\
PB: 48 % of patients reported at least one barrier\
SP: Delay over 3 months (*n* = 21 %)B: NR\
PB: NR\
SP: Lowest socioeconomic group associated with longest time to SP (1.51, 95 % CI: 1.18-1.88\*)GoodFreidman et al. (2006) \[[@CR38]\]Retrospective Quantitative124 women. Mean age: 44.3 yearsUSBreastEmployment, educationB: Fear\
PB: Worry what the symptom might be, difficulty getting an appointment, cost, denial\
SP: Mean time to symptom presentation (9 months)B: NR\
PB: NR\
SP: Lower education associated with longest time to SP (Fishers Exact test, *p* \< 0.01\*\*)MediumGoldsen et al. (1957) \[[@CR61]\]Retrospective Quantitative727 men and womenUSAllIncome, education and occupationK: Symptom interpretation (20 % thought symptoms indicated cancer)\
B: Cancer worry, fatalism\
PB: Poor health service utilization, symptom not noticed\
PF: Symptom disclosure\
SP: 51.3 % sought medical help under 30 daysK: NR\
B: NR\
PB: NR\
PF: NR\
SP: Lower income, education and occupation associated with longest time to SP (statistics NR)MediumGould et al. (2010) \[[@CR39]\]Retrospective Qualitative14 women. Aged range: 30 to 69 yearsCanadaBreastEducation, employment, incomeK: Symptom interpretation (poor for non-lump symptoms)\
B: Fear\
PB: Previous benign disease, watchful waiting, competing life priorities\
PF: Symptom disclosure, already have another appointment booked.\
SP: All women waited 8+ weeksMediumGrant et al. (2010) \[[@CR82]\]Retrospective Qualitative15 men (*n* = 7) and women (*n* = 8). Aged 45 years and underScotlandOralPostcodeK: Symptom interpretation\
PB: Self-medication\
PF: Already had an appointment booked\
SP: Sought medical help within 8 weeks (*n* = 8)MediumGreer (1974) \[[@CR68]\]Retrospective Quantitative160 women with stage I or stage II cancer. Aged 70 years and underUKBreastSocial ClassK: Symptom interpretation\
B: Fear, fatalism\
PB: Embarrassment\
SP: 64 % sought medical help within 1 monthK: NR\
B: NR\
PB: NR\
SP: NS difference between time to SP and social class (statistics NR)PoorHunter et al. (2003) \[[@CR30]\]Hypothetical Quantitative546 women. Mean age: 47 yearsUKBreastOccupationK: Recognition (good, mean 6.65)\
B: Beliefs about treatment\
SP: 58.6 % would seek immediate medical help.K: NR\
NR: NR\
SP: Socioeconomic group not associated with time to SP (F~(1,518)~ = 0.29, *p* \> 0.05)MediumKakagia et al. (2013) \[[@CR34]\]Retrospective Quantitative513 men (*n* = 56.5 %) and women (*n* = 43.5 %). Mean age: 67.5 yearsGreeceSkinEducation, ethnicity, area of residenceK: Symptom interpretation\
B: Fear, fatalism\
PB: Other serious comorbidities, poor health service utilisation, dislike of doctors and hospitals, transport issues, worry about wasting doctors time, embarrassment, competing life demands\
PF: Symptom disclosure, active encouragement to seek medical help\
SP: Mean time to symptom presentation (3.9 months)K: NR\
B: NR\
PB: NR\
PF: NR\
SP: Longer time to SP associated with lower socioeconomic group (OR 1.89, 95 % CI: 0.9-3.8. *p* \< 0.001) and lower education (OR 3.01, 95 % CI: 1.6-5.6, *p* \< 0.001)MediumLam et al. (2009) \[[@CR63]\]Retrospective Qualitative37 women. Age range 20-81 yearsHong KongBreastEmployment, educationK: Symptom interpretation\
B: fear, fatalism\
PB: Watchful waiting, poor general health service utilisation, cost, competing life priorities, embarrassment\
PF: Persistence of symptoms, appearance of new symptom, symptom disclosure, symptom interfering with daily life, appointment booked for another reason\
SP: Waited over 3 months to seek medical help (*n* = 14)MediumLi et al. (2012) \[[@CR65]\]Retrospective Quantitative425 women. Mean age: 51.97 yearsHong KongBreastEmployment, educationB: Fear\
PB: Cost, gender of doctor, unsure where to seek medical help, competing life priorities, no history of breast problems, symptom disclosure\
PF: Symptom disclosure\
SP: Median time to symptom presentation (14 days)B: NR\
PB: Symptom disclosure for women with lower education less likely to translate into immediate SP (*x*^2^ = 6.4, d.f. = 2, *p* \< 0.05)\
PF: NR\
SP: Longer time to SP associated with higher education (OR 3.35, 95 % CI:1.19-9.42, *p* \< 0.05) and full time employment (OR 2.52, 95 % CI: 1.18-5.36, *p* \< 0.05)GoodLoehrer et al. (1991) \[[@CR71]\]Retrospective Qualitative128 men (*n* = 33) and women (*n* = 95). Mean age: 63 yearsUSAllEmployment, income, educationB: Curability of cancer, cancer is contagious, surgery causes cancer to spread\
SP: Poor for non-specific symptomsMediumLow et al. (2013) \[[@CR31]\]Hypothetical Quantitative1000 women. Mean age: 47 yearsUKOvarianEducation, car ownership, home ownershipK: Recall (poor, mean 0.6) and recognition (good, mean 6.3)\
PB: Mean number of barriers endorsed (2.2), emotional, practical and service barriers\
SP: Varied by symptom, most would seek help under 2 weeksK: NR\
PB: NR\
SP: Higher socioeconomic group associated with longer time to SP (beta = 0.12, SE 0.05, *p* \< 0.001\*\*)GoodMagarey et al. (1977) \[[@CR72]\]Retrospective Quantitative64 women. Age in years: less than 40 (*n* = 13), 40-60 (*n* = 28), over 60 (*n* = 23).AustraliaBreastEducationPB: Denial, anxiety\
SP: Most sought medical help within 2 weeks (*n* = 35)PB: NR\
SP: Education not associated with time to SP (statistics NR)PoorMarlow et al. (2014) \[[@CR78]\]Hypothetical Qualitative54 women from ethnic minority groups living with a comparison of white women. Age range: 25-64 yearsUKBreast and OvarianEmployment, education, living arrangementK: Recall (good for lumps/ bleeding, poor for other symptoms)\
B: Fear, fatalism, benefits of early diagnosis\
PB: Poor relationship with GP, emotional barriers, practical barriers, service barriers, competing life priorities\
PF: Symptom disclosure\
SP: Varied: days to months. All sought help within 3 months.MediumMcCaffery et al. (2003) \[[@CR50]\]Hypothetical Quantitative1637 men (*n* = 763) and women (*n* = 874). Age range: 16-74 yearsUKColorectalEducationK: Recall (poor)\
B: Fear\
SP: 92.8 % would anticipate seeking medical help if noticed blood in stool for more than 2 weeks.K: Higher education associated with higher symptom recall (*x*^2^ \[[@CR4]\] = 73.98, *p* \< 0.001)\
B: Lower education associated with most negative beliefs (*x*^2^ \[[@CR4]\] = 74.96, *p* \< 0.001)\
SP: NS association with education and SP intentions (statistics NR)GoodMeechan et al. (2003) \[[@CR46]\]Retrospective Mixed85 women. Mean age: 38.9 yearsNew ZealandBreastEducationPB: Having a family member with cancer, low emotional response to symptom\
PF: High emotional response to symptom\
SP: Median time to symptom presentation (14 days)PB: NR\
PF: NR\
SP: NS association between education and time to SP (t (83) = -1.26, *p* \> 0.05)MediumMor (1990) \[[@CR74]\]Retrospective\
Mixed700 patients. Age range: 45 to 90 yearsUSLung, Breast and ColorectalEducation, housing, income, educationK: Symptom interpretation (best knowledge for breast cancer patients)\
B: Fear (16.8 % of delayers)\
PB: ''thought it would go away" (60.5 % of delayers), too busy (8.4 % of delayers)\
SP: Waited over 3 months to seek medical help: lung (54.9 %), breast (56.2 %), colorectal (87.6 %)K: NR\
B: NR\
PB: NR\
SP: NS relationship between socioeconomic group and time to SP (statistics NR)MediumOliveria et al. (1999) \[[@CR37]\]Retrospective Quantitative255 men and women. Aged 18 years and overUSMelanomaEducation, insuranceK: Recognition (poor)\
SP: Mean time to symptom presentation (2 months)K: NR\
SP: Education not associated with time to SP (statistics NR)MediumO'Mahony and Hegarty (2009) \[[@CR47]\]Retrospective Quantitative99 women. Mean age: 40 yearsIrelandBreastEmployment, educationK: Symptom interpretation\
PB: Competing life priorities, emotional reactions to symptom (afraid, scared, unsure)\
PF: Symptom disclosure, anxiety\
SP: Waited over 1 month to seek medical help (*n* = 26)K: NR\
PB: NR\
PF: NR\
SP: Higher education associated with longer time to SP (statistics NR)MediumO'Mahony et al. (2011) \[[@CR79]\]Retrospective Qualitative10 women. Mean age: 40 yearsIrelandBreastEducation, employment, insuranceK: Most aware that a lump was a symptomof cancer\
B: Fatalism, curability of cancer, fear\
PB: Denial, competing life priorities\
PF: Symptom disclosure, good perceived access to GP, good relationship with GP\
SP: Sought medical help within 1 month (*n* = 6)MediumPedersen et al. (2011) \[[@CR85]\]Retrospective Quantitative901 men (*n* = 423) and women (*n* = 487). Mean age: 61.8 yearsDenmarkAllEducationPF: Symptom disclosure, good partner support\
SP: Median interval: 12 daysPF: NR\
SP: NS association between education and time to SP: Lower secondary education and long SP (\>55 days) (RRR 0.79, 95 % CI: 0.36-1.74, *p* \> 0.05); tertiary education and long SP (\>55 days) (RRR 1.30, 95 % CI: 0.55-3.08, *p* \> 0.05)MediumQuaife et al. (2014) \[[@CR32]\]Hypothetical Quantitative6965 men (*n* = 4330) and women (*n* = 265). Aged 50 and overUKAllEducationK: Recognition (best for 'lump')\
PB: Poor access health services\
SP: Would wait 2+ weeks: (cough, *n* = 48.1 %; breast change, *n* = 8.2 %; rectal bleeding, *n* = 7.4 %)K: Lower education associated with lower recognition for all 3 symptoms (*x*^2^, *p* \< 0.05\*\*)\
PB: NR\
SP: Lower education associated with shorter time to SP for cough (OR 0.61, 95 % CI: 0.54-0.68, *p* \< 0.001) and breast changes (OR 0.68, 95 % CI: 0.52-0.89, *p* \< 0.001). NS association with education and time to SP for rectal bleeding (OR 0.83, 95 % CI: 0.67-1.03, *p* \> 0.05)GoodRauscher et al. (2010) \[[@CR66]\]Retrospective Quantitative438 women. Age range: 30 to 79 yearsUSBreastEducation, household income, health insurance statusK: Breast lump misconceptions (20 % reported one or more misconception)\
PB: Poor general health service utilisation\
SP: Waited over 3 months to seek medical help (16 %)K: Lower income and education associated with more breast lump misconceptions (*x*^2^, *p* \< 0.001\*\*)\
PB: NR\
SP: Longer time to SP associated with lower education (*x*^2^, *p* \< 0.05\*\*) and lower income (*x*^2^, *p* \< 0.05\*\*)MediumRichard et al. (2000) \[[@CR77]\]Retrospective Quantitative590 men (*n* = 250) and women (*n* = 340). Mean age: 51.2 yearsFranceMelanomaResidence, social level, educationK: Symptom interpretation ('not serious', 34.8 %)\
B: Fear\
PB: No symptoms, competing life priorities (work and family commitments), melanoma not detected by participant\
PF: Active encouragement from family\
SP: Sought medical help within 2 months (51.9 %)K: NS\
B: NS\
PB: Those with higher education more likely to self-detect melanoma (*x*^2^, *p* \< 0.01\*\*)\
PF: NR\
SP: NS association with and time to SP and socioeconomic group (statistics NR)MediumRozniatowski et al. (2005) \[[@CR73]\]Retrospective Quantitative100 men (*n* = 84) and women (*n* = 16). Mean age: 57 yearsFranceHead and NeckEducation, occupationPB: Low anxiety, poor general health service utilisation\
PF: Symptom disclosure, active encouragement from partner to seek help\
SP: The majority of patients waited over 1 week to seek medical helpK: NR\
PB: NR\
SP: NS association between socioeconomic group and time to SP (statistics NR)MediumRistvedt et al. (2014) \[[@CR33]\]Retrospective Quantitative112 men (*n* = 55) and women (*n* = 57). Mean age: 59.3 yearsUSColorectalIncome, area of residence, education, health insuranceK: Symptom interpretation (70.5 % thought symptom serious within 13 weeks post onset)\
SP: Median time to symptom presentation (10 weeks)K: NR\
SP: NS association between socioeconomic group (education and household income) and time to SP (statistics NR)MediumRistvedt and Trinkhaus (2005) \[[@CR9]\]Retrospective Quantitative69 men (*n* = 42) and women (*n* = 27). Mean age: 61.3 yearsUSColorectalEducationK: Symptom interpretation ('not cancer', 71 %)\
PB: Personality (low trait anxiety), poor health service utilisation\
SP: Mean time to symptom presentation (25 weeks)K: NR\
PB: NR\
SP: Lower education associated with longer time to SP (Kaplan-Meier: median 15 weeks, 95 % CI: 9.0-26.0\*); higher education associated with shorter time to SP (Kaplan-Meier: median 8 weeks, 95 % CI: 4.0-15.0\*)MediumRobb et al. (2009) \[[@CR19]\]Hypothetical Quantitative2216 men (*n* = 968) and women (*n* = 1240)UKAllEducation, occupationK: Recall (poor, mean = 2.2) and recognition (good, mean = 7.2)\
PB: Emotional and service barriers most endorsed\
SP: Most would seek medical help within 2 weeksK: Higher socioeconomic group (occupation) associated with highest knowledge (F (2,2015) = 20.31, *p* \< 0.001)\
PB: Lower socioeconomic group (occupation) associated with more emotional barriers endorsed: 'worry what the doctor might find' (*x*^2^ (1,1989) = 17.08, *p* \< 0.001), 'too embarrassed' (*x*^2^ (1,1993) = 20.74, *p* \< 0.001), 'not confident to talk about symptom' (*x*^2^ (1,1992) = 4.77, *p* \< 0.05), NS association with 'too scared' (*x*^2^ (1,1977) = 1.82, *p* \> 0.05); Higher socioeconomic group (occupation) associated with more practical barriers endorsed: 'too busy' (*x*^2^ (1,2005) = 59.0, *p* \< 0.001), 'other things to worry about' (*x*^2^(1,1996) = 15.34, *p* \< 0.001), 'difficult to arrange transport' (*x*^2^(1,2010) = 11.13, *p* \< 0.001); NS association between socioeconomic group (occupation) and service barriers: 'difficult to make appointment' (*x*^2^ (1,1983) = 0.41, *p* \> 0.05), 'worried about wasting the doctors time' (*x*^2^ (1,1995) = 1.44, *p* \> 0.05), 'difficult to arrange transport' (*x*^2^ (1,1938) = 1.15, *p* \> 0.05)\
SP: Lower socioeconomic group (occupation) associated with shorter time to SP for unexplained bleeding (*x*^2^ (1,1991) = 5.82, *p* \< 0.01), difficulty swallowing (*x*^2^ (1,1987) = 28.41, *p* \< 0.001), lump (*x*^2^(1,1988) = 21.26, *p* \< 0.001), change in mole (*x*^2^ (1,1967) = 24.24, *p* \< 0.001), unexplained pain (*x*^2^(1,1965) = 20.24, *p* \< 0.001), sore that does not heal (*x*^2^ (1,1977) = 35.84, *p* \< 0.001), change in bowel/bladder habits (*x*^2^ (1,1982) = 56.87, *p* \< 0.001), cough (*x*^2^ (1,1984) = 48.32, *p* \< 0.001), unexplained weight loss (*x*^2^ (1,1963) = 77.73, *p* \< 0.001)GoodSamet et al. (1988) \[[@CR62]\]Retrospective Quantitative800 men (*n* = 396) and women (*n* = 404). Mean age: 72.2 yearsUSAllEducation, incomePB: Poor general health service utilisation, poor access\
SP: Most sought medical help within 2 monthsPB: NR\
SP: Longer time to SP associated with lower income for breast and colorectal cancer (*x*^2^, *p* \< 0.05\*\*) and lower education for all tumour sites (*x*^2^, *p* \< 0.05\*\*)MediumSchmid-Wendter (2002) \[[@CR40]\]Retrospective Quantitative233 men (*n* = 109) and women (*n* = 109). Mean age: 54.5 yearsGermanyMelanomaEducationK: Previous knowledge of melanoma, symptom interpretation\
B: Fear\
PB: Lesion not visible, too busy\
SP: Sought medical help within 1 month (15.5 %)K: Higher education more likely to have knowledge about melanoma (*x*^2^, *p* \< 0.001\*\*)\
B: NR\
PB: NR\
SP: NRMediumSiminoff et al. (2014) \[[@CR35]\]Retrospective Mixed methods252 men (*n* = 132) and women (*n* = 120). Mean age: 58 years (range 25 to 94 years)USColorectalEducation, Employment, IncomeK: Symptom interpretation (39.7 % did not think symptom was serious)\
PB: Financial barriers (28.6 %), fear of diagnostic tests (24.3 %), embarrassment (11.9 %)\
SP: Mean appraisal delay (4.8 months)K: NR\
PB: NR\
SP: NS association between time to SP and socioeconomic group (statistics NR)MediumSimon et al. (2010) \[[@CR49]\]Retrospective Quantitative236 men (*n* = 968) and women (*n* = 1240). 11.4 % (*n* = 236) had experienced a symptom in the past 3 monthsUKAllOccupationK: Recognition (better knowledge if experienced a symptom previously); symptom interpretation (worry symptom might be cancer)\
PB: Emotional and practical barriers\
SP: Symptom experience: 11.4 % experienced symptom in past 3 months (75 % consulted a GP about symptom)K: NS association between symptom interpretation and socioeconomic group (statistics NR)\
PB: NR\
SP: NS association between SP and socioeconomic group (statistics NR)GoodSmith and Anderson (1985) \[[@CR51]\]Retrospective Quantitative82 women. Age range: 20 to 54 yearsUSOvarianIncome, education, occupationK: Symptom interpretation ('cancer', 10 %)\
B: Fear\
PB: Previous benign diagnosis\
SP: Median time to symptom presentation (4 weeks)K: NS association between symptom interpretation and socioeconomic group (statistics NR)\
B: NR\
PB: NR\
SP: NRMediumTemoshok et al. (1983) \[[@CR75]\]Retrospective Quantitative106 men and women. Age range: 18 to 72 years.USMelanomaEducation, occupationK: Previous knowledge of melanoma\
B: Melanoma not a serious disease\
PF: Lesion visible (face and neck)\
SP: Mean time to symptom presentation (4 months)K: No association with knowledge and occupation (statistics NR)\
B: NR\
PF: NR\
SP: No association with time to SP and occupation (statistics NR)PoorTod et al. (2008) \[[@CR80]\]Retrospective Qualitative20 men (*n* = 12) and women (*n* = 8).UKLungOccupationK: Symptom interpretation (poor, symptoms usually interpreted as acute conditions)\
B: Fear, fatalism\
PB: If previously given up smoking (thought risk of lung cancer was nil), worry about the wasting doctors time, previous bad experiences with health system, blame, stigma, stoicism, poor health service utilisation\
PF: Active encouragement from family member\
SP: Range in time to symptom presentation (0 to 24 months)GoodTomlinson et al. (2012) \[[@CR60]\]Retrospective Quantitative87 men (*n* = 56) and women (*n* = 31). Mean age: 65 years.CanadaColorectalEducationK: Symptom interpretation\
PB: Self medication\
SP: Waited over 1 month to seek medical help (51 %)K: NR\
PB: NR\
SP: NS association between education and time to SP (*x*^2^, *p* \> 0.05\*\*)MediumTrivers et al. (2011) \[[@CR52]\]Hypothetical Quantitative2991 women. 65 % were aged 45 years and over.USGynaeco-logicalEducation, IncomeB: Concern about developing gynaecological cancer\
PB: Being premenopausal\
SP: 50 % of women would seek help for most symptomsB: NR\
PB: NR\
SP: NS association between SP intentions and socioeconomic group (statistics NR)MediumVan Osch et al. (2007) \[[@CR48]\]Hypothetical Quantitative459 men (49 %) and women (51 %) over the age of 55. Mean age: 68.6 years.NetherlandsAllEducationK: Recognition (low to moderate, mean: 6.2)\
B: Benefits of early detection\
SP: Fair. Inconsistent for urgent symptoms, good for prolonged symptomsK: NR\
B: NR\
SP: Lower education associated with shorter time to SP (F (2,436) =6.084, *p* \< 0.01)GoodWaller et al. (2009) \[[@CR53]\]Hypothetical Quantitative1500 men and women from various ethnic minority groups.EnglandAllOccupationK: Recall (poor, mean: 1.2) and recognition (poor, mean: 4.7)\
PB: Worry what doctor might find (most endorsed)\
SP: African and Caribbean groups anticipated fastest time to symptom presentationK: Higher socioeconomic group associated with higher recall (F(1,1487) = 6.12, *p* \< 0.01) and higher recognition (F (1,1487) = 5.45, *p* \< 0.05)\
PB: NR\
SP: NRGoodWalter et al. (2014) \[[@CR41]\]Retrospective\
Qualitative63 men (*n* = 31) and women (*n* = 32). Age range: 29-93 years.UKMelanomaEducationK: Symptom attributions (initially attributed to benign skin conditions or normal life changes)\
PB: Worry about wasting the doctors time, service barriers, competing life priorities, reassurance following symptom disclosure\
PF: Family history of melanoma, perceptions of high risk, symptom disclosure, symptom noticed by another person\
SP: Range 1-303 weeksGoodWhitaker et al. (2014) \[[@CR55]\]Retrospective Quantitative1724 men (*n* = 789) and women (*n* = 921) over the age of 50. Mean age: 64.4 years.EnglandAllPostcode, education, employmentK: Symptom interpretations (2 % thought symptom was cancer, highest interpretation for 'unexplained lump'), perceived seriousness of symptoms\
SP: Symptom experience (53 % experienced at least 1 symptom in past 3 months). 59 % contacted GP about symptomK: Unemployment associated with higher perceived seriousness of pain (OR 2.26, 95 % CI: 1.17-4.35, *p* \< 0.05), tiredness (OR 2.11, 95 % CI:1.23-3.64, *p* \< 0.05), sore throat (OR 3.56, 95 % CI: 1.10-11.45, *p* \< 0.05) and chest pain (OR 3.56, 95 % CI: 1.10-11.45, *p* \< 0.05). Lower education associated with higher perceived seriousness cough (OR 2.25, 95 % CI: 1.10-4.56, *p* \< 0.05), tiredness (OR 2.46, 95 % CI:1.44-4.21, *p* \< 0.05), headaches (OR 3.80, 95 % CI: 1.63-8.89, *p* \< 0.05), shortness of breath (OR 2.34, 95 % CI: 1.11-4.97, *p* \< 0.05), sore throat (OR 4.16, 95 % CI: 1.14-15.22, *p* \< 0.05) and chest pain (OR 4.16, 95 % CI: 1.13-15.22, *p* \< 0.05)\
SP: NRGoodWhitaker et al. (2015) \[[@CR81]\]Retrospective Qualitative48 men (*n* = 23) and women (*n* = 25) over the age of 50. Mean age: 64.4 years.EnglandAllEducation, employmentK: Symptom interpretations (symptoms normalised or associated with cancer)\
PB: Stoicism, fear of diagnostic tests, worry about wasting doctors time, service barriers, negative attitudes towards HCPs, medical mistrust\
PF: Development of new symptoms, persistence of symptoms, symptom disclosure, fear\
SP: Varied per symptom: 33.3 % contacted GP with 'persistent cough', 100 % contacted GP with 'unexplained bleeding'Good*K* = cancer symptom knowledge; *B* = beliefs about cancer; *PB* = perceived barriers to symptom presentation; *PF* = perceived facilitators to symptom presentation; *SP* = time to symptom presentation; *NR* = not reported; *NS* = not significant; \**p*-value not reported; \*\*other statistics not reported

Symptom presentation {#Sec9}
--------------------

Studies involving anticipated symptom presentation reported shorter time to symptom presentation compared with studies that examined actual time to symptom presentation. In the former, most participants anticipated seeking medical help within one week \[[@CR28]--[@CR30]\] or within one month \[[@CR19], [@CR31], [@CR32]\], in contrast to real-world studies where it was more common for patients to have waited over two months before seeking medical help \[[@CR33]--[@CR41]\]. The most prompt actual and anticipated symptom presentation was reported for lumps \[[@CR32], [@CR38], [@CR42]--[@CR47]\] or bleeding \[[@CR19], [@CR32], [@CR48]--[@CR53]\]. Studies examining participants who reported experiencing a potential symptom of cancer in the past three months found between 59 % and 75 % of participants had consulted a doctor about their symptom \[[@CR49], [@CR54], [@CR55]\].

Disparity between actual and anticipated symptom presentation relating to socioeconomic group was observed. In five studies, shorter anticipated time to symptom presentation was observed in lower compared to higher socioeconomic groups \[[@CR19], [@CR28], [@CR31], [@CR32], [@CR48]\]. Conversely, in two studies, longer anticipated time to symptom presentation was reported in those from lower socioeconomic groups compared with higher socioeconomic groups \[[@CR56], [@CR57]\].

Studies which measured actual time to symptom presentation reported the longest delays in symptom presentation among individuals with lower educational attainment \[[@CR33], [@CR34], [@CR42], [@CR54], [@CR58]--[@CR61]\], lower annual income \[[@CR61], [@CR62]\], lower occupation and employment \[[@CR43], [@CR61], [@CR63]\] and those from deprived areas \[[@CR64]\]. This effect was also observed in studies of actual symptom presentation where multiple socioeconomic indices were reported \[[@CR34], [@CR42], [@CR44], [@CR61], [@CR65], [@CR66]\]. Twenty-two studies found no group differences for socioeconomic group indicators and time to symptom presentation \[[@CR30], [@CR33], [@CR35]--[@CR37], [@CR45], [@CR46], [@CR49], [@CR50], [@CR52], [@CR60], [@CR67]--[@CR77]\].

Knowledge {#Sec10}
---------

Knowledge of symptoms based on recall methods was generally lower than in studies that used recognition methods. Lump symptoms were the most recalled and well-recognised potential cancer symptom \[[@CR19], [@CR32], [@CR48], [@CR50], [@CR53], [@CR56], [@CR64], [@CR78]\]. This was supported by retrospective studies where patients presenting with a lump were most likely to have attributed their lump symptom to cancer \[[@CR39], [@CR43], [@CR45], [@CR74], [@CR79]\]. Knowledge was generally poor for non-specific symptoms of cancer. Symptoms such as fatigue or unexplained weight loss were poorly recalled or recognised as potential symptoms of cancer \[[@CR28], [@CR29], [@CR31], [@CR53], [@CR78]\]. Poorer cancer symptom knowledge was associated with lower socioeconomic group when measured by educational attainment \[[@CR28], [@CR32], [@CR40], [@CR50], [@CR54], [@CR56]\], occupation \[[@CR53]\] and multiple indicators \[[@CR19], [@CR28], [@CR66]\]. These findings were consistent across site-specific and non site-specific studies, suggesting poor general cancer symptom knowledge in lower socioeconomic groups regardless of cancer type.

In retrospective studies, patients experiencing non-specific symptoms recalled attributing them to other benign causes or life stresses \[[@CR35], [@CR51], [@CR55], [@CR65], [@CR69], [@CR76], [@CR80], [@CR81]\] or not recognising the seriousness of their symptoms \[[@CR9], [@CR33], [@CR35], [@CR37], [@CR40], [@CR42], [@CR43], [@CR45], [@CR47], [@CR51], [@CR54], [@CR55], [@CR57], [@CR60], [@CR65], [@CR68], [@CR76], [@CR77], [@CR81], [@CR82]\] resulting in patients delaying symptom presentation \[[@CR35], [@CR39], [@CR51], [@CR76]\] or later stage at diagnosis \[[@CR69]\].

Beliefs about cancer {#Sec11}
--------------------

In most studies, beliefs were formed from participants' past experiences of cancer, usually witnessing friends or family with the disease \[[@CR36], [@CR43], [@CR47], [@CR59], [@CR78], [@CR79]\]. Positive beliefs were identified in nine studies \[[@CR30], [@CR36], [@CR43], [@CR48], [@CR54], [@CR58], [@CR78], [@CR79]\] and tended to focus on the effectiveness of modern cancer treatments, where participants expressed trust in doctors and the medical system and endorsed the benefits of early diagnosis \[[@CR30], [@CR58], [@CR59], [@CR78]\] or acknowledged that cancer can be cured \[[@CR78]\]. Such beliefs tended to encourage timely symptom presentation to a primary care physician \[[@CR30], [@CR58], [@CR59], [@CR78], [@CR79]\]. One study found that those with lower educational attainment were less likely to endorse positive beliefs about the benefits of early detection \[[@CR54]\].

Negative beliefs tended to manifest in fear or fatalism regarding cancer. Fear was frequently reported across all studies examining beliefs. This included fear of diagnosis \[[@CR34], [@CR39], [@CR58], [@CR63], [@CR74], [@CR80], [@CR81], [@CR83]\], fear of treatment \[[@CR30], [@CR43], [@CR57]--[@CR59], [@CR68], [@CR78], [@CR83]\] and fear of dying \[[@CR59], [@CR78], [@CR83]\]. Fatalistic beliefs were a common theme throughout studies, but were expressed only by a minority of participants per study \[[@CR34], [@CR36], [@CR42], [@CR56], [@CR59], [@CR61], [@CR78], [@CR79], [@CR84]\]. Fearful and fatalistic beliefs about cancer were more likely to be expressed by individuals from lower socioeconomic groups based on educational attainment \[[@CR36], [@CR50]\] or multiple indices \[[@CR42], [@CR71]\].

When considering time to symptom presentation, fearful beliefs about cancer appeared to operate at the two extremes of immediate or prolonged symptom presentation. For participants whose fearful beliefs encouraged immediate (actual or hypothetical) presentation to doctors \[[@CR43], [@CR45], [@CR58], [@CR59], [@CR61], [@CR74], [@CR78], [@CR79], [@CR84]\], a visit to doctors was used to alleviate anxiety associated with the symptom \[[@CR43], [@CR47], [@CR58], [@CR59], [@CR61], [@CR77], [@CR78]\]. This was usually coupled with the participant expressing trust in the medical profession and positive beliefs surrounding early diagnosis \[[@CR43], [@CR59]\].

For individuals whose fearful beliefs led to prolonged delays (sometimes years) \[[@CR30], [@CR34], [@CR38], [@CR39], [@CR43], [@CR47], [@CR51], [@CR61], [@CR68], [@CR74], [@CR78], [@CR79]\], denial of or ignoring symptoms initially alleviated anxiety associated with the symptom \[[@CR38], [@CR39], [@CR47], [@CR59], [@CR68], [@CR72], [@CR76], [@CR78], [@CR79]\]. Such beliefs were usually combined with fatalistic beliefs such as 'cancer cannot be cured' \[[@CR59], [@CR61], [@CR79]\], and were associated with the longest times to symptom presentation or were expressed by those with advanced stage disease \[[@CR36], [@CR56], [@CR59], [@CR84]\]. This is likely to reflect a lack of perceived benefit in presenting to doctors due to the belief that 'nothing can be done' \[[@CR59], [@CR78]\].

Barriers to symptom presentation {#Sec12}
--------------------------------

Some participants reported service barriers relating to concerns about wasting doctors' time \[[@CR19], [@CR29], [@CR31], [@CR34], [@CR41], [@CR43], [@CR55], [@CR80], [@CR81]\], lack of continuity with primary care doctor \[[@CR42], [@CR81]\] or difficulties with accessing and making an appointment \[[@CR29], [@CR32], [@CR34], [@CR38], [@CR53], [@CR55], [@CR56], [@CR65], [@CR78], [@CR81]\]. For others, practical barriers such as being 'too busy to make an appointment' were reported and these delayed symptom presentation \[[@CR31], [@CR39], [@CR40], [@CR43], [@CR49], [@CR74], [@CR77], [@CR78]\]. Low general health service utilisation for acute or long term conditions lengthened time to cancer symptom presentation \[[@CR9], [@CR34], [@CR42], [@CR43], [@CR57], [@CR58], [@CR61], [@CR66], [@CR68], [@CR73], [@CR77], [@CR78], [@CR80], [@CR84]\]. Emotional barriers included embarrassment or fear associated with undergoing intimate diagnostic tests \[[@CR19], [@CR29], [@CR31], [@CR34], [@CR35], [@CR49], [@CR57], [@CR78], [@CR81]\].

Practical barriers such as 'being too busy' were more frequently reported in high socioeconomic groups \[[@CR19]\]. In countries where patients pay for their healthcare, those with lower annual income were more likely to report the cost of a consultation as a barrier to symptomatic presentation \[[@CR38], [@CR63]\].

Facilitators to symptom presentation {#Sec13}
------------------------------------

The most common facilitator of symptom presentation was disclosure of symptoms to a family member or friend \[[@CR34], [@CR39], [@CR41], [@CR43], [@CR45], [@CR47], [@CR55], [@CR61], [@CR65], [@CR70], [@CR73], [@CR76]--[@CR79], [@CR81], [@CR84], [@CR85]\]. In some cases, this reduced time to symptom presentation by half \[[@CR36]\] or by six times \[[@CR45]\]. The appearance of a new symptom \[[@CR43], [@CR69], [@CR76], [@CR83]\] or persistence of the current symptom \[[@CR45], [@CR69], [@CR76], [@CR81], [@CR84]\] facilitated decisions to seek medical help. One study found that individuals from a lower socioeconomic group who disclosed their symptom to a family member or friend took longer to seek medical help compared to those from a higher socioeconomic group \[[@CR65]\]. In five studies, participants waited until they developed another health complaint or tagged their cancer symptom on to the end of a consultation which provided an opportunity to disclose the cancer symptom during the consultation \[[@CR42], [@CR45], [@CR68], [@CR81], [@CR82]\].

Discussion {#Sec14}
==========

This review is the first to systematically explore how knowledge, beliefs and barriers/facilitators to symptom presentation affect actual or anticipated cancer symptom presentation in relation to socioeconomic group, across all tumour sites. Poor knowledge of non-specific cancer symptoms such as fatigue and weight loss prolonged presentation due to misattribution of symptoms in lower socioeconomic groups. In contrast, lump and bleeding symptoms were most frequently recalled, recognised and prompted the fastest symptom presentation. A knowledge gradient was observed, where poorer cancer symptom knowledge was associated with lower socioeconomic group based on multiple indices. There was some evidence to suggest that those from a lower socioeconomic group were more likely to hold fearful and fatalistic beliefs about cancer and less likely to endorse positive beliefs about the benefits of early diagnosis. Such combinations of fearful and fatalistic beliefs were associated with prolonged symptom presentation. In addition, emotional barriers to symptom presentation such as worry what the doctor might find were more likely to be endorsed in lower socioeconomic groups. Such poor knowledge and prevalent beliefs might account for the long actual delays and later stage cancers diagnosed in lower socioeconomic groups. Disclosure of a symptom to a family member or friend was a key facilitator in the decision to seek medical help, although there was some evidence to suggest that symptom disclosure acted as a barrier in lower socioeconomic groups.

Most included studies were of medium quality. In many studies, socioeconomic group was measured but not reported for all outcome variables. Most studies only reported socioeconomic group differences for symptom presentation. Twenty-three studies reported socioeconomic group differences for the other outcome measures: knowledge, beliefs and barriers/facilitators to symptom presentation. A further eight studies could have met the inclusion criteria, but were excluded due to non-reporting of any outcomes associated with socioeconomic group \[[@CR14], [@CR86]-[@CR92]\]. Methodological limitations included a long duration between cancer diagnosis and participation in retrospective studies, and samples biased towards higher socioeconomic groups. In some studies, socioeconomic variation was insufficient to perform statistical analysis on all outcomes.

There are methodological limitations associated with retrospective (actual symptom presentation) and hypothetical (anticipated symptom presentation) designs. Whilst retrospective studies are affected by recall bias, hypothetical studies rely on intentions which may not translate into actual presentation behaviour \[[@CR93]\]. This was observed in the variation between actual and hypothetical time to symptom presentation, where participants anticipated prompt symptom presentation but in reality reported longer delays. Study designs exploring actual symptom presentation behaviour in a population sample are likely to reduce some of the limitations associated with retrospective and hypothetical symptom presentation study designs. In such study designs, participants disclose actual symptoms experienced in the past three months, usually prompted by a list (without any mention of cancer), and reasons for not consulting a doctor are explored \[[@CR49], [@CR54], [@CR55], [@CR81]\].

The limitations of this review include problems relating to retrieval of studies and analysis of the evidence. Due to poor indexing of studies in this topic area under the MeSH indexing in this topic area, a high proportion of studies (*n* = 11) was found through hand-searching. Additionally, meta-analysis was precluded by the wide range of qualitative and quantitative data collection methods of included studies. Finally, other factors such as age, gender and ethnicity can affect symptom presentation \[[@CR6], [@CR18]\]; however, interactions between these variables and socioeconomic group were not addressed in the current review.

The findings of the current review confirm that failure to appreciate the seriousness of symptoms \[[@CR6], [@CR16]\] and non-disclosure of symptoms \[[@CR6], [@CR15]\] lengthened time to symptom presentation. Our findings accord with previous studies in which negative beliefs \[[@CR20]\], longer time to actual symptom presentation \[[@CR6]\] and low suspicion for cancer symptoms \[[@CR94]\] were associated with low socioeconomic group \[[@CR6]\]. The current findings support Mitchell et al.*'*s (2008) \[[@CR16]\] review of colorectal cancer patients, in which fear of cancer either lengthened or shortened time to symptom presentation. Such findings might be explained by Type I and Type II information processing systems. Type I processing is a fast and automatic system, which represents an individual's 'gut reaction' to an event, whereas Type II is a slower, more thoughtful and deliberative system \[[@CR95]\]. Whilst most people initially experience fear in reaction to a worrying symptom (Type I processing), cognitions during Type II processing may influence the decision to seek medical help since these are slower and may help someone to rationalise the situation \[[@CR96]\]. If an individual has had time to consider the benefits of seeking medical help, and based upon their previous beliefs about early diagnosis, such beliefs may override the Type 1 fear response. We found evidence to suggest a higher prevalence of fearful and fatalistic beliefs in lower socioeconomic groups and some evidence for fewer positive beliefs surrounding the benefits of early diagnosis in lower socioeconomic groups. This suggests that Type I beliefs may not be overridden by Type 2 responses relating to the benefits of early diagnosis due to lower knowledge or higher emotive responses. As a consequence this may delay symptom presentation. Findings relating to symptom disclosure suggest that people use the 'lay system' of healthcare (consulting family and friends) before making the decision to access formal healthcare \[[@CR13], [@CR97], [@CR98]\]. However, among individuals from low socioeconomic groups, disclosing symptoms to someone with equally poor knowledge and Type I negative automatic beliefs about cancer may encourage false reassurance in the benign nature of symptoms and consequently no urgency to seek medical help.

Cancer awareness interventions should be carefully developed to target those who are most likely to present with advanced stage disease: lower socioeconomic groups with low symptom knowledge and fearful and fatalistic beliefs about cancer. Such an intervention should utilise an individual's social networks to facilitate distribution of information \[[@CR97]\], highlighting the significance of non-lump symptoms as potentially indicative of cancer, along with advice on an appropriate time in which an individual should seek medical help and how to access such help \[[@CR99]\]. This should be coupled with information outlining the benefits of early diagnosis and improved effectiveness of modern treatments for cancer, countering negative beliefs surrounding cancer. Future research should evaluate the effectiveness of such interventions in lower socioeconomic groups.

Conclusion {#Sec15}
==========

Knowledge of potential cancer symptoms, beliefs about cancer and barriers to symptom presentation work in combination to influence symptom presentation: knowledge is necessary for accurate symptom appraisal, but beliefs about cancer and barriers to symptom presentation influence the decision to seek medical help or not. This is especially important in the context of socioeconomic deprivation, where lower knowledge, higher negative beliefs about cancer and perceived barriers may lead to avoidable delays, later stage of diagnosis and ultimately poorer survival outcomes. Targeted interventions should not only educate people about symptoms for cancer, but also work to break down unhelpful myths surrounding cancer survival and treatment options. They should address the barriers that people in lower socio-economic groups experience, and use social networks to raise awareness and support early symptom presentation.

Additional file {#Sec16}
===============
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NAEDI

:   National awareness and early diagnosis initiative

SPIDER

:   Sample phenomenon of interest, design, evaluation, research type

CASP

:   Critical appraisal skills programme

OECD

:   Organisation for economic co-operation and development
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